The effect of human mobility and control measures on the COVID-19 epidemic in China.
Journal
Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511
Informations de publication
Date de publication:
01 05 2020
01 05 2020
Historique:
received:
03
03
2020
accepted:
23
03
2020
pubmed:
28
3
2020
medline:
6
5
2020
entrez:
28
3
2020
Statut:
ppublish
Résumé
The ongoing coronavirus disease 2019 (COVID-19) outbreak expanded rapidly throughout China. Major behavioral, clinical, and state interventions were undertaken to mitigate the epidemic and prevent the persistence of the virus in human populations in China and worldwide. It remains unclear how these unprecedented interventions, including travel restrictions, affected COVID-19 spread in China. We used real-time mobility data from Wuhan and detailed case data including travel history to elucidate the role of case importation in transmission in cities across China and to ascertain the impact of control measures. Early on, the spatial distribution of COVID-19 cases in China was explained well by human mobility data. After the implementation of control measures, this correlation dropped and growth rates became negative in most locations, although shifts in the demographics of reported cases were still indicative of local chains of transmission outside of Wuhan. This study shows that the drastic control measures implemented in China substantially mitigated the spread of COVID-19.
Identifiants
pubmed: 32213647
pii: science.abb4218
doi: 10.1126/science.abb4218
pmc: PMC7146642
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
493-497Subventions
Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019510/1
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : U54 GM088558
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI128344
Pays : United States
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Commentaires et corrections
Type : UpdateOf
Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Références
Ann Intern Med. 2020 Apr 21;172(8):567-568
pubmed: 32023340
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Lancet Infect Dis. 2014 Jan;14(1):50-56
pubmed: 24239323
Science. 2018 Aug 31;361(6405):894-899
pubmed: 30139911
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6146-51
pubmed: 15071187
Euro Surveill. 2020 Jan;25(4):
pubmed: 32019669
Emerg Infect Dis. 2020 May;26(5):1049-1052
pubmed: 32053479
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32080723
Science. 2020 May 1;368(6490):493-497
pubmed: 32213647
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Science. 2020 May 8;368(6491):638-642
pubmed: 32234804
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11157-62
pubmed: 16055564
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Nat Microbiol. 2019 May;4(5):854-863
pubmed: 30833735
Epidemiology. 2017 Jan;28(1):136-144
pubmed: 27748685
Biochem Med (Zagreb). 2013;23(2):143-9
pubmed: 23894860
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
Lancet. 2020 Mar 7;395(10226):764-766
pubmed: 32105609
Sci Data. 2020 Mar 24;7(1):106
pubmed: 32210236
Sci Data. 2019 Dec 13;6(1):318
pubmed: 31836720
Lancet Infect Dis. 2020 May;20(5):534
pubmed: 32087115
Lancet Infect Dis. 2009 May;9(5):291-300
pubmed: 19393959